| Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, and interest expense for the three months ended February 29, 2024 and February 28, 2023:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
|
|
February 29, 2024 |
|
|
February 28, 2023 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,805,522 |
|
|
$ |
7,561,518 |
|
PrepaCyte CB |
|
|
3,000 |
|
|
|
32,200 |
|
Public cord blood banking |
|
|
43,713 |
|
|
|
230,697 |
|
Total net revenue |
|
$ |
7,852,235 |
|
|
$ |
7,824,415 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,884,566 |
|
|
$ |
1,687,250 |
|
PrepaCyte CB |
|
|
25,483 |
|
|
|
17,122 |
|
Public cord blood banking |
|
|
250,419 |
|
|
|
362,992 |
|
Total cost of sales |
|
$ |
2,160,468 |
|
|
$ |
2,067,364 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,057,719 |
|
|
$ |
1,807,693 |
|
PrepaCyte CB |
|
|
(29,428 |
) |
|
|
8,133 |
|
Public cord blood banking |
|
|
(207,068 |
) |
|
|
(132,655 |
) |
Total operating profit |
|
$ |
821,223 |
|
|
$ |
1,683,171 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
25,879 |
|
|
$ |
273,539 |
|
PrepaCyte CB |
|
|
6,945 |
|
|
|
6,945 |
|
Public cord blood banking |
|
|
362 |
|
|
|
360 |
|
Total depreciation and amortization |
|
$ |
33,186 |
|
|
$ |
280,844 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
256,459 |
|
|
$ |
466,231 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
256,459 |
|
|
$ |
466,231 |
|
The following table shows the assets by segment as of February 29, 2024 and November 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
February 29, 2024 |
|
|
November 30, 2023 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
56,017,726 |
|
|
$ |
55,471,149 |
|
PrepaCyte CB |
|
|
125,757 |
|
|
|
148,040 |
|
Public cord blood banking |
|
|
5,567,291 |
|
|
|
5,601,581 |
|
Total assets |
|
$ |
61,710,774 |
|
|
$ |
61,220,770 |
|
|